Charles Balch, President of the International Society of Oncology Prevention and Treatments, shared a post on LinkedIn about a paper by Laura J. Esserman et al. published in JAMA:
“This is a landmark study. It defines 4 risk groups of women and then has a standardized schedule for the age and interval of mammograms: high risk, elevated risk, average risk, and low risk. Equally important is the finding of the low-risk women who can be spared the cost and anxiety of having mammograms at an age and frequency without benefit. No more ‘one size fits all approach’!”
Title: Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial
Authors: Laura J. Esserman, Allison S. Fiscalini, Arash Naeim, Laura J. van‘t Veer, Andrea Kaster, Maren T. Scheuner, Andrea Z. LaCroix, Alexander D. Borowsky, Hoda Anton-Culver, Olufunmilayo I. Olopade, James Esserman, Rachael Lancaster, Lisa Madlensky, Amie M. Blanco, Katherine S. Ross, Deborah L. Goodman, Barry S. Tong, Michael Hogarth, Diane Heditsian, Susie Brain, Vivian Lee, Kelly Blum, Mi-Ok Kim, Leah P. Sabacan, Kirkpatrick B. Fergus, Christina Yau, Hannah L. Park, Barbara A. Parker, Celia Kaplan, Kim F. Rhoads, Suzanne Eder, Kelly Adduci, Jeffrey B. Matthews, Neil S. Wenger, Yiwey Shieh, Robert A. Hiatt, Elad Ziv, Jeffrey A. Tice, and Martin Eklund
You can read the Full Article in JAMA.
More posts featuring Charles Balch.